The human gut microbiota contributes to type-2 diabetes non-resolution 5-years after Roux-en-Y gastric bypass

Roux-en-Y gastric bypass (RYGB) is efficient at inducing drastic albeit variable weight loss and type-2 diabetes (T2D) improvements in patients with severe obesity and T2D. We hypothesized a causal implication of the gut microbiota (GM) in these metabolic benefits, as RYGB is known to deeply impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Debédat, Jean, Le Roy, Tiphaine, Voland, Lise, Belda, Eugeni, Alili, Rohia, Adriouch, Solia, Bel Lassen, Pierre, Kasahara, Kazuyuki, Hutchison, Evan, Genser, Laurent, Torres, Licia, Gamblin, Camille, Rouault, Christine, Zucker, Jean-Daniel, Kapel, Nathalie, Poitou, Christine, Marcelin, Geneviève, Rey, Federico E., Aron-Wisnewsky, Judith, Clément, Karine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037437/
https://www.ncbi.nlm.nih.gov/pubmed/35435140
http://dx.doi.org/10.1080/19490976.2022.2050635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037437/
https://www.ncbi.nlm.nih.gov/pubmed/35435140
http://dx.doi.org/10.1080/19490976.2022.2050635

Ejemplares similares